Filter
2441
Filtered Results: 2441
Text search:
mass
drug
Featured
Recommendations
235
New Publications
689
Language
Document type
No document type
1432
Studies & Reports
398
Guidelines
291
Manuals
118
Strategic & Response Plan
118
Training Material
31
Fact sheets
30
Infographics
9
Situation Updates
8
Brochures
2
Resource Platforms
2
Online Courses
2
Countries / Regions
India
163
Global
110
Kenya
77
Ethiopia
72
Uganda
64
Nepal
50
South Africa
50
Sierra Leone
49
Liberia
48
Zambia
48
Western and Central Europe
48
Nigeria
46
Rwanda
45
Bangladesh
43
Malawi
41
Ghana
40
Tanzania
40
Philippines
34
Myanmar / Burma
33
Ukraine
31
Africa
29
Namibia
26
Latin America and the Carribbean
26
Cambodia
21
Eastern Europe
21
Syria
20
Zimbabwe
19
South–East Asia Region
19
Congo, Democratic Republic of
18
Indonesia
18
Mozambique
18
West and Central Africa
17
Senegal
16
Lesotho
14
East and Southern Africa
14
Asia
14
South Sudan
13
Eswatini/ Swaziland
12
Botswana
11
Russia
11
Burkina Faso
9
Haiti
9
Brazil
9
Middle East and North Africa
9
Guinea
7
USA
6
Pakistan
6
Afghanistan
6
Germany
6
Eastern Europe and Central Asia
6
Venezuela
6
Cameroon
5
Somalia
5
Thailand
5
Sudan
5
Yemen
5
Western Pacific Region
5
Peru
4
Madagascar
4
Laos
4
Tajikistan
4
Iran
4
Vietnam
4
North America
4
United Kingdom
4
Iraq
3
Jordan
3
Lebanon
3
Turkey
3
Central African Republic
3
Burundi
3
Colombia
3
El Salvador
3
Sri Lanka
3
Bhutan
3
Timor Leste/ East Timor
3
Georgia
3
Mali
2
Saudi Arabia
2
China
2
Papua New Guinea
2
Argentina
2
Bolivia
2
Libya
2
Mexico
2
Chile
2
Albania
2
Southern Africa
2
Morocco
1
Niger
1
Egypt
1
Chad
1
Gambia
1
Singapore
1
Benin
1
North Macedonia
1
Honduras
1
Ecuador
1
Greece
1
Angola
1
Paraguay
1
Poland
1
Palestine
1
North Korea
1
Djibouti
1
Armenia
1
Mongolia
1
Canada
1
Estonia
1
Lithuania
1
Moldova
1
Kyrgyzstan
1
Kazakhstan
1
Turkmenistan
1
France
1
Mauritius
1
Tunisia
1
Portugal
1
Spain
1
Azerbaijan
1
Belarus
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1090
Clinical Guidelines
235
Public Health
170
Women & Child Health
89
Key Resources
69
Capacity Building
35
Pharmacy & Technologies
20
Annual Report MEDBOX
1
Protection & Security
1
Toolboxes
COVID-19
152
HIV
144
Mental Health
140
TB
140
NTDs
138
NCDs
84
Rapid Response
78
AMR
71
Conflict
54
Pharmacy
52
Planetary Health
49
Caregiver
45
Ebola
36
Refugee
36
Global Health Education
28
Natural Hazards
25
Disability
17
Cholera
17
Specific Hazards
14
Zika
11
Health Financing Toolbox
10
Social Ethics
7
Polio
4
South Sudan
1
The environment in which young people live, learn and play significantly affects their decisions about whether to consume alcohol. Environmental factors are the main risk factors driving alcohol consumption and related harm among young people. Environments that normalize alcohol consumption – term...
The key actions, activities, and approaches in this document are organized within each of the 5Cs (see Table 1 in the PDF) and those of the Strategic preparedness and response plan (SPRP) pillars as follows:
National action plan key activities, prioritized for the current context and the current ...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
Cardiovascular diseases (CVDs) have collectively remained the leading causes of death worldwide and substantially contribute to loss of health and excess health system costs. The Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study has tracked trends in death and disability since 1990 a...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nationally representative data on the current patterns...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South
American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention
and rehabilitation (CVDPR). In the context of the imple...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f...
Hypertension is the number one health related risk factor in India, with the largest contribution to burden of disease and mortality. It contributes to an estimated 1.6 million deaths, due to ischemic heart disease and stroke, out of a total of about 10 million deaths annually in India. Fifty seven ...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
The Public Health Burden of Commercial Tobacco Use
The burden of disease and death from commercial tobacco* use in the United States is
overwhelmingly caused by cigarettes and other combustible tobacco products.
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a comprehensive strategy to address the global rise in noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, chronic respiratory diseases,...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
Care for persons with noncommunicable diseases (NCDs), such as cardiovascular disease, diabetes, cancer, and chronic obstructive pulmonary disease, is a major health priority for most countries worldwide, particularly for low-middle income countries where the problem seems to be worsening. Globally,...
Language influences the way we think, how we perceive reality, and how we behave. With respect to HIV, language can embody stigma and discrimination, which impacts access to testing, acquisition of HIV, and engagement with treatment. Language plays a role in supporting respect and empowerment of ind...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
This document defines the framework for Malawi’s National HIV Programs. Considering public health benefits and risks, as well as funding and resource implications, deviations from these guidelines are not supported by the Ministry of Health.
